// App-Quantinova.ai

: Glycaemic and metabolic effects of testosterone replacement in hypogonadal men with uncontrolled type 2 diabetes − a randomised double blinded placebo controlled trial − stride study

Researchers

Presenter

  • Preethi Mohan Rao

Principal Investigators

  • Daniel M Kelly

  • T. Hugh Jones

Medical Centers

  • Barnsley Hospital NHS Foundation Trust, Robert Hague Centre for Diabetes and Endocrinology, United Kingdom

  • The University of Sheffield, Human Metabolism and Oncology, United Kingdom

  • Sheffield Hallam University, Biomolecular Research Centre, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Endocrine/metabolic Diseases (ME)

Disease

  • Type 2 diabetes mellitus

Biomarkers

  • Hemoglobin A1c

  • Telomerase reverse transcriptase

  • Body mass index

  • Twist-related protein 2

Drug/Treatment

  • LPCN 1111

  • Nebido

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Controlled

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved